Therefore, MDS diagnosis may be unclear in the setting of a plasma cell dyscrasia, leading to ambiguity as to the etiology of cytopenia. New cytopenia arising in such cases creates clinical challenges and therapy choice is nuanced. Co-occurrent MGUS and MDS has been previously described [8,9...